4/9
12:05 pm
dnli
Rating for DNLI
Low
Report
Rating for DNLI
2/29
09:56 am
dnli
Rating for DNLI
Medium
Report
Rating for DNLI
2/29
09:56 am
dnli
Rating for DNLI
Medium
Report
Rating for DNLI
2/29
09:56 am
dnli
Rating for DNLI
Medium
Report
Rating for DNLI
2/28
08:17 am
dnli
Denali Therapeutics Inc. (NASDAQ: DNLI) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $31.00 price target on the stock.
High
Report
Denali Therapeutics Inc. (NASDAQ: DNLI) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $31.00 price target on the stock.
2/28
08:17 am
dnli
Denali Therapeutics Inc. (NASDAQ: DNLI) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $31.00 price target on the stock.
High
Report
Denali Therapeutics Inc. (NASDAQ: DNLI) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $31.00 price target on the stock.
2/28
07:48 am
dnli
Rating for DNLI
High
Report
Rating for DNLI
2/28
07:48 am
dnli
Rating for DNLI
High
Report
Rating for DNLI
2/22
08:06 am
dnli
Denali Therapeutics Inc. (NASDAQ: DNLI) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $105.00 price target on the stock.
Low
Report
Denali Therapeutics Inc. (NASDAQ: DNLI) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $105.00 price target on the stock.